These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22253134)

  • 21. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global tests for combination drug studies in factorial trials.
    Hung HM
    Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
    Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
    Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of treatments in a combination therapy trial.
    Patel HI
    J Biopharm Stat; 1991; 1(2):171-83. PubMed ID: 1844694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Propensity score methods for creating covariate balance in observational studies].
    Pattanayak CW; Rubin DB; Zell ER
    Rev Esp Cardiol; 2011 Oct; 64(10):897-903. PubMed ID: 21872981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
    J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T; Gittins J
    Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy].
    Ke YN; Huang J; Zhu JR;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):794-9. PubMed ID: 20128376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent clinical trials in hypertensiology].
    Kurlapska E; Goch JH; Kasprzak K; Goch A
    Pol Merkur Lekarski; 2010 Jun; 28(168):473-7. PubMed ID: 20642108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: rationale and design.
    Ogihara T; Matsuzaki M; Matsuoka H; Shimamoto K; Shimada K; Rakugi H; Umemoto S; Kamiya A; Suzuki N; Kumagai H; Ohashi Y; Takishita S; Abe K; Saruta T;
    Hypertens Res; 2005 Apr; 28(4):331-8. PubMed ID: 16138563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large sample tests for simultaneous comparison to multiple controls in terms of binomial proportions.
    Soulakova JN; Luo L
    J Biopharm Stat; 2013 May; 23(3):589-603. PubMed ID: 23611197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stratified doubly robust estimators for the average causal effect.
    Hattori S; Henmi M
    Biometrics; 2014 Jun; 70(2):270-7. PubMed ID: 24571129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Introduction to an individual-based standardization method -- propensity score weighting].
    Li ZW; Liu JM; Ren AG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb; 31(2):223-6. PubMed ID: 21215089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach.
    Yang S; Li F; Thomas LE; Li F
    Clin Trials; 2021 Oct; 18(5):570-581. PubMed ID: 34269087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls.
    Yuan J; Liu J; Zhu R; Lu Y; Palm U
    J Biopharm Stat; 2019; 29(3):558-573. PubMed ID: 30612514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two treatments on a covariate variable.
    Lin TY; Liao CT; Li CR; Tsai JR; Liu YT
    J Biopharm Stat; 2020 Jul; 30(4):649-661. PubMed ID: 32163305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doubly robust estimation of the weighted average treatment effect for a target population.
    Tao Y; Fu H
    Stat Med; 2019 Feb; 38(3):315-325. PubMed ID: 30302780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.